mainly with regards to antibacterial agents. Therapeutic applications of the immunomodulatory properties of various antibacterial drugs are widely acknowledged. For instance, dapsone and ...

Few papers have analyzed the possible additional immunomodulatory activity of antiviral agents. In particular, cellular uptake, a critical property for these intracellular acting drugs is not studied.

Thanks to the expected introduction of several late-stage pipeline products. The type 1 diabetes (T1D) market across the ...

The type 1 diabetes (T1D) market across the seven major markets (7MM: USA, France, Germany, Italy, Spain, the UK, and Japan) ...

Thus, we are testing several immunomodulatory agents with distinct mechanisms of action to determine which may provide benefit when paired with VIR-2218. • VIR-2218 with PEG-IFN-α: PEG-IFN-α ...

Global Type 1 diabetes market is set to grow at a compound annual growth rate (CAGR) of 13.3 per cent from $2.2 billion in ...

Camrelizumab is under clinical development by Elevar Therapeutics and currently in Pre-Registration for Hepatocellular Carcinoma.